Hybridization capture-based sequencing as a novel diagnostic for simultaneous identification and AMR profiling of bacterial pathogens causing canine urinary tract infections

Active Cooperative Agreement Awarded

Award ID
U18FD008925
Recipient
Awarding agency
Obligated
$56,122

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 18% complete
Funding agency
Food and Drug Administration Department of Health and Human Services
Place of performance
Urbana, IL 61801, USA

Award details come from USAspending.gov.

Description

Abstract
Whole genome sequencing (WGS) is commonly used for investigation of bacterial infection in animals. WGS usually requires pathogen isolation as the first step, which might delay the investigation process. In this proposal, we request funding to evaluate probe capture-based enrichment method for sequencing canine urine bacteria and AMR genes directly from clinical urine samples. The outcomes of this project may improve diagnosis and treatment of bacterial urine tract infections in dogs through precision-based identification. The proposed study will expand the VET-lirn's capacity for antimicrobial stewardship by implementing precision-based diagnostics for canine urinary tract infections, which will have important impacts for both public and veterinary health.

Quick answers

Who received award U18FD008925?

U18FD008925 was awarded to University Of Illinois by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008925 worth?

$56,122 has been obligated on U18FD008925.

Which agency awarded U18FD008925?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008925, with funding from Food and Drug Administration (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award